Page last updated: 2024-10-29

isradipine and Hypertrophy

isradipine has been researched along with Hypertrophy in 1 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to ascertain if Isradipine treatment in spontaneously hypertensive rats (SHR) decreased hypertension-dependent left ventricular and coronary vascular hypertrophy."7.69Influence of isradipine treatment on left ventricular and coronary vascular hypertrophy in spontaneously hypertensive rats. ( Amenta, F; Ferrante, F, 1994)
"The purpose of this study was to ascertain if Isradipine treatment in spontaneously hypertensive rats (SHR) decreased hypertension-dependent left ventricular and coronary vascular hypertrophy."3.69Influence of isradipine treatment on left ventricular and coronary vascular hypertrophy in spontaneously hypertensive rats. ( Amenta, F; Ferrante, F, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrante, F1
Amenta, F1

Other Studies

1 other study available for isradipine and Hypertrophy

ArticleYear
Influence of isradipine treatment on left ventricular and coronary vascular hypertrophy in spontaneously hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1994, Volume: 16, Issue:1

    Topics: Animals; Blood Pressure; Coronary Vessels; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular;

1994